Thalidomide salvages lethal hepatic necroinflammation and accelerates recovery from cirrhosis in rats

Journal of Hepatology

Volumn 41, Issue 4, 2004, Pages 606-612

  Yeh, Ta Sen ^a,b   Ho, Yu Pin ^a   Huang, Shiu Feng ^a   Yeh, Jun Nan ^a   Jan, Yi Yin ^a   Chen, Miin Fu ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b Surgical Lab   (Canada)

Author keywords

Cirrhosis; Kupffer cells; TGF 1; Thalidomide; TNF

Indexed keywords

MESSENGER RNA; THALIDOMIDE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEPATITIS; HISTOPATHOLOGY; KUPFFER CELL; LIVER CIRRHOSIS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM;

ANIMALS; COLLAGENASES; HEPATITIS; KUPFFER CELLS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 13; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; SALVAGE THERAPY; THALIDOMIDE; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644323842     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.019     Document Type: Article

References (35)

1. T. Poynard, J. McHutchison, M. Manns, C. Trepo, K. Lindsay, and Z. Goodman Impact of Pegylated interferon Alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 2002 1303 1313
2. J. Zhu, J. Wu, E. Frizell, S.-L. Liu, R. Bashey, and R. Rubin Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an vivo model of liver fibrosis Gastroenterology 117 1999 1198 1204
3. Z. Qi, N. Atsuchi, A. Ooshima, A. Takeshita, and H. Ueno Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rats Proc Natl Acad Sci USA 96 1999 2345 2349
4. R. Oren, I. Dotan, M. Papa, Y. Marravi, A. Husin, and J. Barg Inhibition of experimentally induced cirrhosis in rats by hypothyroidism Hepatology 24 1996 419 423
5. H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenata, R. Noguchi, and D.J. Hicklin Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis Gut 52 2003 1347 1354
6. E.J. Williams, R.C. Benyon, N. Trim, R. Hadwin, B.H. Grove, and M.J. Arthur Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo Gut 49 2001 577 583
7. Y. Matsuda, K. Matsumoto, A. Yamada, T. Ichida, H. Asakura, and Y. Komoriya Preventive and therapeutic effects in rats of hepatocyte growth factor infusion o liver fibrosis/cirrhosis Hepatology 26 1997 81 89
8. Y. Imuro, T. Nishio, T. Morimoto, T. Nitta, B. Stefanovic, and S.K. Choi Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rats Gastroenterology 124 2003 445 458
9. H. Yoshiji, S. Kuriyama, Y. Miyamoto, U.P. Thorgeirsson, D.E. Gomez, and M. Kawata Tissue inhibitor of metalloproteinase-1 promotes liver fibrosis development in a transgenic mouse model Hepatology 32 2000 1248 1254
10. H. Ueno, T. Sakamoto, T. Nakamura, Z. Qi, N. Astuchi, and A. Takeshita A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats Human Gene Ther 11 2000 33 42
11. J. George, D. Roulot, V.E. Koteliansky, and D.M. Bissel In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis Proc Natl Acad Sci USA 96 1999 12719 12724
12. H. Tilg, R. Jalan, A. Kaser, N.A. Davies, F.A. Offner, and S.J. Hodges Anti-tumor necrosis factor-alfa monoclonal antibody therapy in severe alcoholic hepatitis J Hepatol 38 2003 419 425
13. A.L. Mreira, E.P. Sampaio, A. Zmuidzinas, P. Frindt, K.A. Smith, and G. Kaplan Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation J Exp Med 177 1993 1675 1680
14. E.D. Ehrenpreis, S.V. Kane, L.B. Cohen, R.D. Cohen, and S.B. Hanauer Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial Gastroenterology 117 1999 1271 1277
15. G. Reyes-Teran, J.G. Sirrra-Madero, V. Martinez del Cerro, H. Arroyo-Figueroa, A. Pasquetti, and J.J. Calva Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial Aids 10 1996 1501 1507
16. R.J. Stevens, C. Andujar, C.J. Edwards, P.R. Ames, A.R. Barwick, and M.A. Khamashta Thalidomide in the treatment of the cutaneous manifestation of lupus erythematous: experience in sixteen consecutive patients Br J Rheumatol 36 1997 353 359
17. G.B. Vogelsang, E.R. Farmer, A.D. Hess, V. Altamonte, W.E. Beschorner, and D.A. Jabs Thalidomide for the treatment of chronic graft-versus-host disease N Engl J Med 326 1992 1055 1058
18. P. Muriel, E. Fernandez-Martinez, V. Perez-Alvarez, F. Lara-Ochoa, S. Ponce, and J. Garcia Thalidomide ameliorates carbon tetrachloride induced cirrhosis in the rats Eur J Gastroenterol Hepatol 15 2003 951 957
19. E. Fernandez-Martinez, M.S. Morales-Rios, V. Perez-Alvarez, and P. Muriel Effect of thalidomide and 3-phthalimido-3-(3,4-dimethoxyphenyl)-propanamide on bile duct obstruction-induced cirrhosis in the rat Drug Dev Res 54 2001 209 218
20. A. Muller, F. Machnick, T. Zimmermann, and H. Schubert Thioacetamide-induced cirrhosis-like lesions in rats-usefulness and reliability of this animal model Exp Pathol 34 1988 229 234
21. Y. Yang, S. Harvey, and C.R. Gandhi Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver J Hepatol 39 2003 200 207 TNFα
22. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
23. R.G. Knodell, K.G. Ishak, W.C. Black, T.S. Chen, R. Craig, and N. Kaplowitz Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis Hepatology 1 1981 431 435
24. V.J. Desmet, M. Gerber, J.H. Hoofnagle, M. Manns, and P.J. Scheuer Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1519
25. N. Enomoto, Y. Takei, M. Hirose, K. Ikejima, H. Miwa, and T. Kitamura Thalidomide prevents alcoholic injury in rats through suppression of Kupffer cell sentilization and TNF-α production Gastroenterology 123 2002 291 300
26. J.A. Keifer, D.C. Guttridge, B.P. Ashburner, and A.S. Baldwin Jr Inhibition of NF-kappa B activity by thalidomide through suppression of Ikappa B kinase activity J Biol Chem 276 2001 22382 22387
27. D.R. Edwards, G. Murphy, J.J. Reynolds, S.E. Whitham, A.J. Docherty, and P. Angel Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor EMBO J 6 1987 1899 1904
28. R.A. Ignotz, T. Endo, and J. Massague Regulation of fibronectin and type 1 collagen mRNA level by transforming growth factor- (J Biol Chem 262 1987 6443 6446
29. M.G. Bachem, D.M. Meyer, R. Melchior, K.M. Sell, and A.M. Gressner Activation of rat perisinusoidal lipocytes by transforming growth factor derived from myofibroblast-like cell - a potential mechanism of self perpetuation in liver fibrogenesis J Clin Invest 89 1992 19 27
30. S.L. Friedman, F.J. Roll, J. Boyles, and D.M. Bissel Hepatic lipocytes: the principal collagen-producing cells of normal rat liver Proc Natl Acad Sci USA 82 1985 8581 8685
31. W.A. Border, and N.A. Noble Transforming growth factor beta in tissue fibrosis N Engl J Med 10 1994 1286 1292
32. J.P. Iredale Cirrhosis: new research provides a basis for rational and targeted treatments BMJ 327 2003 143 147
33. J.P. Iredale, R.C. Benyon, J. Pickering, M. McCullen, M. Northrop, and S. Pawley Mechanism of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J Clin Invest 102 1998 538 549
34. S. Milani, H. Herbst, D. Schppan, H. Stein, and C. Surrenti Transforming growth factor-beta 1 and beta 2 are differentially expressed in fibrotic liver disease Am J Pathol 139 1991 1221 1229
35. K.M. Win, F. Charlotte, A. Mallat, D. Cherqui, N. Martin, and P. Masvier Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet derived growth factor Hepatology 18 1993 137 145